The Global Cell Banking Outsourcing Market witnessed substantial growth, reaching a valuation of USD 11.03 billion in 2022, with projections soaring to USD 33.12 billion by 2029, exhibiting a robust CAGR of 17.01%. This burgeoning market is integral to the biopharmaceutical sector, playing a pivotal role in the development and production of biologic drugs, cell-based therapies, and vaccines.